Mapping the Genomes of Medicinal Plants
Credit: Chris 73 / Wikimedia Commons
Illumina and the Institute of Medicinal Plant Development (IMPLAD) have signed a deal to create the world’s first catalog of genomic references for medicinal plants used as sources in Traditional Chinese Medicines (TCM). TCM has evolved over thousands of years to combine modern medicine with ancient Chinese medicinal practice, including various forms of herbal medicine, acupuncture, and massage.
TCM products represent a large group of medicinal products in East Asia and increasingly around the world, with the annual sales exceeding 60 billion US dollars for pharmaceutical products, and an even larger volume in health foods. However, because pharmaceuticals and health food are made of various plant materials, the lack of chemical consistency has been a challenge to obtain products of consistent quality in terms of safety and effectiveness.
The genomic reference will be established in two phases. The first phase will establish a genomic reference for approximately 500 medicinal plants used in TCM by using Illumina next-generation sequencing (NGS) platforms. After completion and review of the first phase, IMPLAD and Illumina may negotiate a renewal agreement to sequence another 500 medicinal plants to complete the genomic reference for the One Thousand Medicinal Plant Genome (1KMPG). The 1KMPG consortium, organized by Professor Chang Liu from IMPLAD, has maintained live specimens or seeds from more than 5,000 medicinal plant species. Illumina, the global leader in NGS, has expanded its presence and collaborations in China.
“Illumina technologies have been the main driving force in sequencing based in cancer and prenatal health. These methods, when combined with modern drugs, aim to improve people’s lives. It is truly exciting to expand Illumina’s influence in TCM, and to help to standardize the practice of traditional medicine worldwide,” said Molly He, PhD, Illumina’s Senior Director of Research and Head of Illumina’s China Collaboration Center.
“This is the best example of where east meets west. Illumina’s technology will unlock ages of TCM’s mysteries. It may also open another huge market opportunity for Illumina,” said Ruilin Zhao, PhD, Illumina’s General Manager of China.
“Illumina NGS technology will enable researchers to obtain the complete chloroplast genome sequences from the plant species in TCM,” said Professor Xiaobo Sun, IMPLAD’s Director. “This will help to distinguish closely related species that have been traditionally difficult to identify. We anticipate this method can be incorporated into future versions of the Chinese pharmacopeia.”
IMPLAD will collect and annotate all plant species described in the Chinese Pharmacopoeia 2015, an official compendium of drugs covering Traditional Chinese and western medicines. Illumina will sequence all the DNA samples. IMPLAD will then assemble and annotate the complete chloroplast genomes with assistance from Illumina.
“With the rapid development of TCM markets around the world, a genomic reference for the plant species used in Chinese medicine would ensure the quality, safety and effectiveness of TCM products,” said Professor Shilin Chen, Director of the Institute of Materia Medica, an arm of the Chinese Academy of Medical Sciences and Peking Union Medical College.
“We anticipate the results of these findings will aid in the determining the accuracy of biological contents of TCM products around the world,” added Professor Tommy Chen from Yale University and the Chairman of the Consortium for the Globalization of Chinese Medicine.
“It is fascinating to see the synergy between modern and ancient approaches to improve health care together,” said Mostafa Ronaghi, PhD, Senior Vice President and Chief Technology Officer of Illumina.
"Genetic Jenga" Helps Understand How Our Genes Control Our CellsNews
To fully understand how our cells work, we can't focus on just one gene, but must instead look at combinations of genes. Researchers have published a study which knocked out multiple genes, like removing bricks from a Jenga tower, to better understand how they work together.READ MORE
Southeast Asian Nomads Have Evolved to Hunt Fish UnderwaterNews
The human spleen can release oxygenated blood cells to allow more time underwater without breathing. A new study has identified that the "Sea Nomad" Bajau people of Indonesia have evolved larger spleens that would allow them to remain underwater for longer.READ MORE
Gene Therapy Could End Transfusions for Blood Disorder PatientsNews
Beta-thalassemia patients need a regular dose of red blood cells transfused into their body. A new gene therapy that edits faulty genes in the patients' cells could end this monthly ritual.READ MORE
Comments | 0 ADD COMMENT
International Conference on Epigenetics and Epitranscriptomics
Sep 17 - Sep 18, 2018